Top Bio Functions | Â | Â |
---|---|---|
Diseases and Disorders | Â | Â |
Name | p-value1 | Molecules2 |
Cancer 4 | 2.37E-07-1.98E-02 | 35 |
Inflammatory Response | 3.15E-06-2.00E-02 | 23 |
Developmental Disorder | 1.37E-05-1.94E-02 | 8 |
Skeletal and Muscular Disorder | 5.76E-05-1.85E-02 | 33 |
Genetic Disorder | 5.77E-05-2.00E-02 | 54 |
Molecular and Cellular Functions | Â | Â |
Name | p-value | Molecules |
Cell-To-Cell Signaling and Interaction | 3.46E-05-2.00E-02 | 23 |
Lipid Metabolism | 2.49E-04-2.00E-02 | 16 |
Molecular Transport | 2.49E-04-2.00E-02 | 14 |
Small Molecule Biochemistry | 2.49E-04-2.00E-02 | 18 |
Drug Metabolism 4 | 3.71E-04-2.00E-02 | 5 |
Physiological System Development and Function | Â | Â |
Name | p-value | Molecules |
Hematological System Development and Function | 3.46E-05-2.00E-02 | 17 |
Endocrine System Development and Function 4 | 3.71E-04-1.98E-02 | 5 |
Visual System Development and Function 4 | 3.71E-04-3.71E-04 | 2 |
Hematopoiesis | 3.72E-04-2.00E-02 | 8 |
Immune Cell Trafficking | 3.72E-04-1.98E-02 | 16 |
Top Canonical Pathways | Â | Â |
Name | p-value | Ratio 3 |
Glycolysis/Gluconeogenesis | 1.34E-04 | 5/142 (0.035) |
Fructose and Mannose Metabolism | 2.19E-04 | 4/145 (0.028) |
Pentose Phosphate Pathway | 9.13E-04 | 3/89 (0.034) |
Dendritic Cell Maturation | 1.31E-03 | 5/188 (0.027) |
VEGF Signaling | 9.55E-03 | 3/99 (0.03) |